INVO Fertility Inc. Common Stock (IVF)

FairStock Score: 24/100 — RISKY

Key Financials

Strengths

• Generates $950,669 in annual free cash flow (27.2% yield on market cap)
• Revenue growth of 22.6% demonstrates strong top-line momentum

Concerns

• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Altman Z-Score of -7.5 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

INVO Fertility Inc. Common Stock is a micro-cap healthcare company valued at $3 million. Revenue stands at $7 million, though the company is currently unprofitable. From a quality standpoint, INVO shows distressed Altman Z-Score of -7.5 warrants caution and moderate 0.72x debt-to-equity. Growth dynamics show revenue growing at 22.6% and profit growth of -62.2%. Our composite FairStock Score of 24/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

INVO's 23% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $950,669 in annual free cash flow (27.2% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer